Scientific publications

Scientific articles authored by Novo Nordisk

The information you can search here is retrieved via the database Current Contents®, covering 95% of publications within the life science area. Only articles authored by at least one researcher from Novo Nordisk are included in the search results. The database provides easy access to tables of contents, abstracts, bibliographic information, and abstracts from the most recently published issues of leading scholarly journals.

4760 results found.
Showing results 101-120
Journal Author Year
Deutsche Medizinische Wochenschrift

Significance of insulin analogues in the treatment of people with type 2 diabetes

Gallwitz B ; Westrup D ; Schmeisl GW 2014

Distinct Developmental Profile of Lower-Body Adipose Tissue Defines Resistance Against Obesity-Associated Metabolic Complications

Pinnick KE ; Nicholson G ; Manolopoulos KN ; McQuaid SE ; Valet P ; Frayn KN ; Denton N ; Min JL ; Zondervan KT ; Fleckner J ; McCarthy MI ; Holmes CC ; Karpe F 2014

Nucleotides Released From Palmitate-Challenged Muscle Cells Through Pannexin-3 Attract Monocytes

Pillon NJ ; Li YE ; Fink LN ; Brozinick JT ; Nikolayev A ; Kuo MS ; Bilan PJ ; Klip A 2014

Increased Immune Cell Infiltration of the Exocrine Pancreas: A Possible Contribution to the Pathogenesis of Type 1 Diabetes

Rodriguez-Calvo T ; Ekwall O ; Amirian N ; Zapardiel-Gonzalo J ; von Herrath MG 2014

Changes in Glucose and Fat Metabolism in Response to the Administration of a HepatoPreferential Insulin Analog

Edgerton DS ; Moore MC ; Winnick JJ ; Scott M ; Farmer B ; Naver H ; Jeppesen CB ; Madsen P ; Kjeldsen TB ; Nishimura E ; Brand CL ; Cherrington AD 2014

Altered DNA Methylation and Differential Expression of Genes Influencing Metabolism and Inflammation in Adipose Tissue From Subjects With Type 2 Diabetes

Nilsson E ; Jansson PA ; Perfilyev A ; Volkov P ; Pedersen M ; Svensson MK ; Poulsen P ; Ribel-Madsen R ; Pedersen NL ; Almgren P ; Fadista J ; Ronn T ; Pedersen BK ; Scheele C ; Vaag A 2014

Glycoprotein 130 Receptor Signaling Mediates alpha-Cell Dysfunction in a Rodent Model of Type 2 Diabetes

Chow SZ ; Speck M ; Yoganathan P ; Nackiewicz D ; Hansen AM ; Ladefoged M ; Rabe B ; Rose-John S ; Voshol PJ ; Lynn FC ; Herrera PL ; Muller W ; Ellingsgaard H ; Ehses JA 2014

The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates

Gotfredsen CF ; Molck AM ; Thorup I ; Nyborg NCB ; Salanti Z ; Knudsen LB ; Larsen MO 2014

Impact of Type 2 Diabetes Susceptibility Variants on Quantitative Glycemic Traits Reveals Mechanistic Heterogeneity

Dimas AS ; Lagou V ; Barker A ; Knowles JW ; Magi R ; Hivert MF ; Benazzo A ; Rybin D ; Jackson AU ; Stringham HM ; Song C ; Fischer-Rosinsky A ; Boesgaard TW ; Grarup N ; Abbasi FA 2014

Fibroblast Growth Factor 21 (FGF21) and Glucagon-Like Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor- Deficient Mice

Omar BA ; Andersen B ; Hald J ; Raun K ; Nishimura E ; Ahren B 2014

Impaired Leptin Gene Expression and Release in Cultured Preadipocytes Isolated From Individuals Born With Low Birth Weight

Schultz NS ; Broholm C ; Gillberg L ; Mortensen B ; Jorgensen SW ; Schultz HS ; Scheele C ; Wojtaszewski JFP ; Pedersen BK ; Vaag A 2014
Diabetes and Vascular Disease Research

The effect of liraglutide on endothelial function in patients with type 2 diabetes

Nandy D ; Johnson C ; Basu R ; Joyner M ; Brett J ; Svendsen CB ; Basu A 2014
Diabetes Care

The Association of Basal Insulin Glargine and/or n-3 Fatty Acids With Incident Cancers in Patients With Dysglycemia. Diabetes Care 2014;37:1360-1366

Zanders MMJ ; Renehan AG ; Bowker SL ; Carstensen B ; van de Poll-Franse LV ; Johnson JA 2014
Diabetes Care

Contribution of Liraglutide in the Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira)

Buse JB ; Vilsboll T ; Thurman J ; Blevins TC ; Langbakke IH ; Bottcher SG ; Rodbard HW 2014
Diabetes Care

Personal Accounts of the Negative and Adaptive Psychosocial Experiences of People With Diabetes in the Second Diabetes Attitudes, Wishes and Needs (DAWN2) Study

Stuckey HL ; Mullan-Jensen CB ; Reach G ; Burns KK ; Piana N ; Vallis M ; Wens J ; Willaing I ; Skovlund SE ; Peyrot M 2014
Diabetes Care

Effect of Early Multifactorial Therapy Compared With Routine Care on Microvascular Outcomes at 5 Years in People With Screen-Detected Diabetes: A Randomized Controlled Trial The ADDITION-Europe Study

Sandbaek A ; Griffin SJ ; Sharp SJ ; Simmons RK ; Borch-Johnsen K ; Rutten GEHM ; van den Donk M ; Wareham NJ ; Lauritzen T ; Davies MJ ; Khunti K 2014
Diabetes Care

Insulin Sensitivity and Albuminuria: The RISC Study

Pilz S ; Rutters F ; Nijpels G ; Stehouwer CDA ; Hojlund K ; Nolan JJ ; Balkau B ; Dekker JM 2014
Diabetes Care

Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors

Andresdottir G ; Jensen ML ; Carstensen B ; Parving HH ; Rossing K ; Hansen TW ; Rossing P 2014
Diabetes Care

GLP-1 Provoked Severe Hypoglycemia in an Individual With Type 2 Diabetes and a Benign Insulinoma

Ruby RJ ; Armato JP ; Pyke C ; Peters AL 2014
Diabetes Care

RESPONSE TO COMMENT ON HOME ET AL. Predictive and Explanatory Factors of Change in HbA(1c) in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs. Diabetes Care 2014;37:1237-1245

Home PD ; Shen CD ; Hasan MI ; Latif ZA ; Chen JW ; Galvez GG 2014